The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sondell, M., Lundborg, G., & Kanje, M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05731.1999 · Cited by 750 · cited 1×
“These findings are consistent with two recent report”
Cited by
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296
Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A., Kingsman, S. M., Carmeliet, P., & Mazarakis, N. D. (2004) · Nature · doi:10.1038/nature02544 · Cited by 590
From angiogenesis to neuropathology
Greenberg, D. A., & Jin, K. (2005) · Nature · doi:10.1038/nature04481 · Cited by 532
VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection
Storkebaum, E., Lambrechts, D., & Carmeliet, P. (2004) · BioEssays · doi:10.1002/bies.20092 · Cited by 507
Role and Therapeutic Potential of VEGF in the Nervous System
Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., & Carmeliet, P. (2009) · Physiological Reviews · doi:10.1152/physrev.00031.2008 · Cited by 448
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors
Borselli, C., Storrie, H., Benesch-Lee, F., Shvartsman, D., Cezar, C., Lichtman, J. W., Vandenburgh, H. H., & Mooney, D. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903875106 · Cited by 447
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Lange, C., Storkebaum, E., de Almodóvar, C. R., Dewerchin, M., & Carmeliet, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.88 · Cited by 382
Schänzer, A., Wachs, F., Wilhelm, D., Acker, T., Cooper‐Kuhn, C., Beck, H., Winkler, J., Aigner, L., Plate, K. H., & Kuhn, H. G. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00060.x · Cited by 364
Vascular endothelial growth factor stimulates skeletal muscle regeneration in Vivo
Arsic, N., Zacchigna, S., Zentilin, L., Ramirez-Correa, G., Pattarini, L., Salvi, A., Sinagra, G., & Giacca, M. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.007 · Cited by 349
Neurovascular signalling defects in neurodegeneration
Zacchigna, S., Lambrechts, D., & Carmeliet, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2336 · Cited by 345
Rosenstein, J. M., Krum, J. M., & Ruhrberg, C. (2010) · Organogenesis · doi:10.4161/org.6.2.11687 · Cited by 314
Reversal of experimental diabetic neuropathy by VEGF gene transfer
Schratzberger, P., Walter, D. H., Rittig, K., Bahlmann, F. H., Pola, R., Curry, C., Silver, M., Krainin, J. G., Weinberg, D. H., Ropper, A. H., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12188 · Cited by 310
Self-citationDiverse roles for VEGF-A in the nervous system
Mackenzie, F., & Ruhrberg, C. (2012) · Development · doi:10.1242/dev.072348 · Cited by 294
New roles for VEGF in nervous tissue?beyond blood vessels
ROSENSTEIN, J. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.022 · Cited by 282
EGR2 Mutations in Inherited Neuropathies Dominant-Negatively Inhibit Myelin Gene Expression
Nagarajan, R., Svaren, J., Le, N., Araki, T., Watson, M., & Milbrandt, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00282-3 · Cited by 273
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema
Yoon, Y.-S., Murayama, T., Gravereaux, E., Tkebuchava, T., Silver, M., Curry, C., Wecker, A., Kirchmair, R., Hu, C. S., Kearney, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15830 · Cited by 270
Self-citationNerve Growth Factor Promotes Angiogenesis and Arteriogenesis in Ischemic Hindlimbs
Emanueli, C., Salis, M. B., Pinna, A., Graiani, G., Manni, L., & Madeddu, P. (2002) · Circulation · doi:10.1161/01.cir.0000033971.56802.c5 · Cited by 267
Zachary, I. (2005) · Neurosignals · doi:10.1159/000088637 · Cited by 266
Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders
Carmeliet, P., & Storkebaum, E. (2002) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2001.0290 · Cited by 252
Rosenstein, J. M., Mani, N., Khaibullina, A., & Krum, J. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11036.2003 · Cited by 220
Nowacka, M. M., & Obuchowicz, E. (2012) · Neuropeptides · doi:10.1016/j.npep.2011.05.005 · Cited by 157
Raab, S., & Plate, K. H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0228-3 · Cited by 120
Can VEGF reverse diabetic neuropathy in human subjects?
Veves, A., & King, G. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13038 · Cited by 88
Paracrine control of vascularization and neurogenesis by neurotrophins
Emanueli, C., Schratzberger, P., Kirchmair, R., & Madeddu, P. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705458 · Cited by 62
Self-citation
Metadata
- Authors
- Schratzberger, P., Schratzberger, G., Silver, M., Curry, C., Kearney, M., Magner, M., Alroy, J., Adelman, L. S., Weinberg, D. H., Ropper, A. H., & Isner, J. M.
- Venue
- Nature Medicine
- Published
- 2000-04
- Volume
- 6
- Issue
- 4
- Pages
- 405-413
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1513780852
- Cited by
- 248
- References
- 1
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.